Table 2

Description of patients with COVID-19 with or without obstructive sleep apnoea (OSA) and a comparison between non-hospitalised and hospitalised patients with OSA

P valueOSA
OSA hospitalised n=19P value
Age (mean in years, SD)51.9 (17.5)61.3 (12.9)5.60×10−4*56.3 (11.0)66.3 (12.9)0.057
Sex (male) (N, %)147 (36.1)19 (50.0)0.64512 (63.2)7 (36.8)0.776
BMI (mean kg/m2, SD)26.71 (5.27)31.15 (5.56)3.38×10−3*30.91 (5.58)31.37 (5.77)1
Comorbidities or outcomes (N, %)118 (29.0)24 (63.2)1.74×10−4*12 (63.2)12 (63.2)1
Hospitalised (N, %)72 (17.7)19 (50.0)3.21×10−5*
  • Differences between non-OSA versus OSA individuals and non-hospitalised patients with OSA versus hospitalised patients with OSA among COVID-19-positive individuals. 7/19 patients with hospitalisation had OSA diagnosis but did not have any other disease comorbidities P values were based on χ2 test. Fisher’s exact test was used if the sample size was 5. For continuous variables, we used Student’s t-test. BMI was measured of 264 participants including 239 non-OSA and 25 OSA individuals. Comorbidities and outcomes=hypertension, diabetes, coronary heart disease, asthma, chronic obstructive pulmonary disease.

  • *Statistically significant.

  • BMI, body mass index.